DOI:
10.1055/s-00031934
The Journal of Hip Surgery
LinksClose Window
References
Scagliotti GV, Hirsh V, Siena S. , et al.
Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study.
J Thorac Oncol 2012;
7 (12) 1823-1829
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.